Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Durinikova, Anna"'
Autor:
Durinikova, Anna1,2 (AUTHOR), Folta, Adam1 (AUTHOR), Pardy, Filip3 (AUTHOR), Svaton, Jan1,3 (AUTHOR), Drncova, Marie1,2 (AUTHOR), Weinbergerova, Barbora1,2 (AUTHOR), Cetkovsky, Petr4 (AUTHOR), Racil, Zdenek4 (AUTHOR), Jindra, Pavel5 (AUTHOR), Szotkowski, Tomas6 (AUTHOR), Zak, Pavel7 (AUTHOR), Mayer, Jiri1,2,3 (AUTHOR), Jeziskova, Ivana1,2 (AUTHOR)
Publikováno v:
Leukemia & Lymphoma. Dec2022, Vol. 63 Issue 13, p3237-3240. 4p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mechin, Déborah, Durinikova, Anna, Boursier, Guilaine, Andre, Marc, Touitou, Isabelle, Sarrabay, Guillaume
Publikováno v:
Clinical and experimental rheumatology
Clinical and experimental rheumatology, Clinical and Experimental Rheumatology Sas, 2020, 38 (5, suppl.127), pp.129-130
Clinical and experimental rheumatology, 2020, 38 (5, suppl.127), pp.129-130
Clinical and experimental rheumatology, Clinical and Experimental Rheumatology Sas, 2020, 38 (5, suppl.127), pp.129-130
Clinical and experimental rheumatology, 2020, 38 (5, suppl.127), pp.129-130
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a598bfb5447f5d884f5fd2fccc7301dc
https://hal.umontpellier.fr/hal-03176539
https://hal.umontpellier.fr/hal-03176539
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mechin D; CHU Montpellier, University of Montpellier, Department of Medical Genetics, Rare Diseases and Personalized Medicine, Rare and Autoinflammatory Diseases Unit, CEREMAIA Reference Centre, Montpellier, and IRMB, University of Montpellier, INSERM, CHU Montpellier, France., Durinikova A; CHU Montpellier, University of Montpellier, Department of Medical Genetics, Rare Diseases and Personalized Medicine, Rare and Autoinflammatory Diseases Unit, CEREMAIA Reference Centre, Montpellier, France., Boursier G; CHU Montpellier, University of Montpellier, Department of Medical Genetics, Rare Diseases and Personalized Medicine, Rare and Autoinflammatory Diseases Unit, CEREMAIA Reference Centre, Montpellier, France., André M; CHU Clermont-Ferrand, Service de Médecine Interne, Hôpital Gabriel Montpied, Clermont-Ferrand, and Université Clermont Auvergne, Inserm U1071, INRA USC2018, M2iSH, Clermont-Ferrand, France., Touitou I; CHU Montpellier, University of Montpellier, Department of Medical Genetics, Rare Diseases and Personalized Medicine, Rare and Autoinflammatory Diseases Unit, CEREMAIA Reference Centre, Montpellier, and IRMB, University of Montpellier, INSERM, CHU Montpellier, France., Sarrabay G; CHU Montpellier, University of Montpellier, Department of Medical Genetics, Rare Diseases and Personalized Medicine, Rare and Autoinflammatory Diseases Unit, CEREMAIA Reference Centre, Montpellier, and IRMB, University of Montpellier, INSERM, CHU Montpellier, France. guillaume.sarrabay@inserm.fr.
Publikováno v:
Clinical and experimental rheumatology [Clin Exp Rheumatol] 2020 Sep-Oct; Vol. 38 Suppl 127 (5), pp. 129-130. Date of Electronic Publication: 2020 Dec 10.